| Company name | Bio-Reference Laboratories Inc |
| Stock ticker | BRLI |
| Live stock price | [stckqut]BRLI[/stckqut] |
| P/E compared to competitors | Good |
MANAGEMENT EXECUTION
| Employee productivity | Poor |
| Sales growth | Good |
| EPS growth | Good |
| P/E growth | Poor |
| EBIT growth | Good |
ANALYSIS
| Confident Investor Rating | Fair |
| Target stock price (TWCA growth scenario) | $27.49 |
| Target stock price (averages with growth) | $39.57 |
| Target stock price (averages with no growth) | $33.93 |
| Target stock price (manual assumptions) | $31.71 |
The following company description is from Google Finance: http://www.google.com/finance?q=brli
Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health and correctional health care. The Company has a network f approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.